Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2026-01-15 Legal Proceedings Report
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
[기재정정]기타경영사항(자율공시) (상장폐지결정 효력정지 가처분신청)
Legal Proceedings Report Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Legal Proceeding' (specifically an injunction application to suspend a delisting decision). While it mentions delisting, it is a legal update on the status of a court case (transfer of jurisdiction), which falls under 'Legal Proceedings Report' (LTR).
2026-01-15 Korean
증권발행결과(자율공시) (제15회차 CB)
Capital/Financing Update Classification · 98% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of new debt/equity instruments.
2025-12-29 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Olipass Co., Ltd. This is a regulatory filing submitted to the Korea Exchange (KRX) detailing the terms of the financing, including interest rates, conversion prices, and the use of proceeds. Under the provided classification schema, this falls under 'Capital/Financing Update' (CAP) as it specifically details a fundraising activity through debt instruments.
2025-12-18 Korean
분기보고서 (2025.09)
Interim / Quarterly Report Classification · 95% confidence The document is titled '분기보고서' which translates to 'Quarterly Report' and specifies the period as the 3rd quarter of the 20th fiscal year, covering from January 1, 2025 to September 30, 2025. It contains detailed company information, including business overview, capital changes, stock issuance details, and management changes. The length is about 15,000 characters, indicating a substantive report rather than a brief announcement. The content includes financial and operational data typical of an interim or quarterly report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2025
2025-11-11 Korean
반기또는분기매출액미달사실발생
Interim / Quarterly Report Classification · 90% confidence The document reports a shortfall in quarterly sales revenue for a specific quarter (Q3 2025) with detailed financial figures and explanations. It includes specific financial data for the quarter, such as sales amount and reasons for the shortfall. The content is focused on a financial update for a period shorter than a full fiscal year and contains substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is short but contains actual financial data, not just an announcement or certification. Q3 2025
2025-11-11 Korean
기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)
Delisting Announcement Classification · 95% confidence The document is a regulatory announcement regarding the company's listing eligibility and related procedural updates. It references a previous delisting decision and ongoing legal actions affecting the delisting process. The content is brief (561 characters) and serves as a notice rather than a detailed report or financial statement. It does not contain financial data or detailed report content but rather updates on regulatory and listing status matters. Therefore, it fits best under the category of Delisting Announcement (DLST).
2025-11-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.